Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Retrophin Tanks After Neurological Treatment Fails Late-Stage Study
By Tony Owusu
Aug 22, 2019 1:34 PM EDT
PRESS RELEASES
Retrophin, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Feb 13, 2020 5:00 PM EST
STOCKS
Retrophin Tanks After Neurological Treatment Fails Late-Stage Study
By Tony Owusu
Aug 22, 2019 1:34 PM EDT
VIDEO
Martin Shkreli Was Just Convicted on 3 Counts of Securities Fraud
By Daniel Kuhn
Aug 4, 2017 3:20 PM EDT
HEALTH
"There is no longer any cash at the fund level" Shkreli wrote to his investors.
By Melissa Angell
Jun 30, 2017 3:07 PM EDT
STOCKS
Could an exhaustive juror search be part of the Pharma Bro's master plan?
By Melissa Angell
Jun 28, 2017 3:46 PM EDT
CORPORATE GOVERNANCE
Shkreli's Lawyer Attempts to Ban Press...Again
By Melissa Angell
Jun 27, 2017 12:13 PM EDT
HEALTH
The jury selection process for Shkreli's trial got underway Monday and is expected to continue Tues.
By Melissa Angell
Jun 26, 2017 6:39 PM EDT
HEALTH
Pharma Bro's Trial to Begin Today
By Melissa Angell
Jun 26, 2017 10:14 AM EDT
STOCKS
Health care stocks bound for declines after 2016 election
By Scott Gamm
Sep 22, 2016 2:33 PM EDT
VIDEO
Retrophin Announces Positive Results for Kidney Disease Drug
By Anders Keitz
Sep 7, 2016 4:07 PM EDT
MARKETS
Retrophin (RTRX) Stock Price Target Upped at Leerink on Kidney Drug Trial
By Rachel Aldrich
Sep 7, 2016 2:25 PM EDT
STOCKS
Retrophin (with help from Martin Shkreli) advances drug for rare kidney disease
By Adam Feuerstein
Sep 7, 2016 8:35 AM EDT
MARKETS
Retrophin (RTRX) Weak On High Volume Today
By TheStreet Wire
Jul 18, 2016 10:09 AM EDT
MARKETS
Retrophin (RTRX) Is Today's Strong On High Volume Stock
By TheStreet Wire
Jun 22, 2016 10:28 AM EDT
MARKETS
Today's Weak On High Volume Stock: Retrophin (RTRX)
By TheStreet Wire
May 5, 2016 10:01 AM EDT
MARKETS
Retrophin (RTRX) Flagged As Strong On High Volume
By TheStreet Wire
May 4, 2016 10:05 AM EDT
MARKETS
Insider Trading Alert - RTRX, SWK And CVGI Traded By Insiders
By TheStreet Wire
Mar 8, 2016 10:15 AM EST
STOCKS
Feb. 25 premarket briefing: 10 things you should know
By Nora Morrison
Feb 25, 2016 8:32 AM EST
MARKETS
Retrophin (RTRX) Weak On High Volume
By TheStreet Wire
Feb 2, 2016 10:01 AM EST
MERGERS AND ACQUISITIONS
KaloBios distances itself from ex-CEO Martin Shkreli, wants to pay employee bonuses
By Kelsey Butler
Jan 29, 2016 9:48 AM EST
VIDEO
With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'
By Rhonda Schaffler
Jan 21, 2016 3:18 PM EST
OPINION
Despite Shkreli drama, Retrophin looks interesting now
By Rhonda Schaffler
Jan 21, 2016 11:08 AM EST
STOCKS
Dec. 30 Premarket Briefing: 10 Things You Should Know
By Nora Morrison
Dec 30, 2015 7:56 AM EST
STOCKS
Shkreli 'was running Turing like a hedge fund'
By Adam Feuerstein
Dec 20, 2015 4:40 PM EST
